It was found that FA attenuates HFD-induced hypercholesterolemia by activating CYP7A1, the rate-limiting enzyme of classic BAs biosynthesis, via a non-FXR signaling. This evidence concerns the gene CYP7A1 and Hypercholesterolemia.